Literature DB >> 32113662

Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.

Sean Richards1, Joshua Walker1, Masako Nakanishi2, Mostafa Belghasem3, Chimera Lyle1, Nkiruka Arinze4, Marc A Napoleon1, Jonathan D Ravid5, Nicholas Crossland3, Qing Zhao3, Daniel Rosenberg2, Nader Rahimi3, Vipul C Chitalia6.   

Abstract

Casitas B-lineage lymphoma (c-Cbl) is a recently identified ubiquitin ligase of nuclear β-catenin and a suppressor of colorectal cancer (CRC) growth in cell culture and mouse tumor xenografts. We hypothesized that reduction in c-Cbl in colonic epithelium is likely to increase the levels of nuclear β-catenin in the intestinal crypt, augmenting CRC tumorigenesis in an adenomatous polyposis coli (APCΔ14/+) mouse model. Haploinsufficient c-Cbl mice (APCΔ14/+ c-Cbl+/-) displayed a significant (threefold) increase in atypical hyperplasia and adenocarcinomas in the small and large intestines; however, no differences were noted in the adenoma frequency. In contrast to the APCΔ14/+ c-Cbl+/+ mice, APCΔ14/+ c-Cbl+/- crypts showed nuclear β-catenin throughout the length of the crypts and up-regulation of Axin2, a canonical Wnt target gene, and SRY-box transcription factor 9, a marker of intestinal stem cells. In contrast, haploinsufficiency of c-Cbl+/- alone was insufficient to induce tumorigenesis regardless of an increase in the number of intestinal epithelial cells with nuclear β-catenin and SRY-box transcription factor 9 in APC+/+ c-Cbl+/- mice. This study demonstrates that haploinsufficiency of c-Cbl results in Wnt hyperactivation in intestinal crypts and accelerates CRC progression to adenocarcinoma in the milieu of APCΔ14/+, a phenomenon not found with wild-type APC. While emphasizing the role of APC as a gatekeeper in CRC, this study also demonstrates that combined partial loss of c-Cbl and inactivation of APC significantly contribute to CRC tumorigenesis.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32113662      PMCID: PMC7074366          DOI: 10.1016/j.ajpath.2019.10.024

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

Review 1.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

2.  Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development.

Authors:  Allen Mo; Stephen Jackson; Kamini Varma; Alan Carpino; Charles Giardina; Thomas J Devers; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2016-06-27       Impact factor: 5.852

Review 3.  Colonic crypt organization and tumorigenesis.

Authors:  Adam Humphries; Nicholas A Wright
Journal:  Nat Rev Cancer       Date:  2008-05-15       Impact factor: 60.716

4.  The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.

Authors:  Sowmya Shivanna; Itrat Harrold; Moshe Shashar; Rosanna Meyer; Chrystelle Kiang; Jean Francis; Qing Zhao; Hui Feng; Elazer R Edelman; Nader Rahimi; Vipul C Chitalia
Journal:  J Biol Chem       Date:  2015-03-17       Impact factor: 5.157

5.  Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers.

Authors:  Sabine Colnot; Michiko Niwa-Kawakita; Ghislaine Hamard; Cécile Godard; Servane Le Plenier; Christophe Houbron; Béatrice Romagnolo; Dominique Berrebi; Marco Giovannini; Christine Perret
Journal:  Lab Invest       Date:  2004-12       Impact factor: 5.662

6.  Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.

Authors:  Antoine Ménoret; David A Drew; Shingo Miyamoto; Masako Nakanishi; Anthony T Vella; Daniel W Rosenberg
Journal:  Mol Carcinog       Date:  2012-12-19       Impact factor: 4.784

7.  Global patterns and trends in colorectal cancer incidence and mortality.

Authors:  Melina Arnold; Mónica S Sierra; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  Gut       Date:  2016-01-27       Impact factor: 23.059

8.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

9.  SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.

Authors:  Philippe Blache; Marc van de Wetering; Isabelle Duluc; Claire Domon; Philippe Berta; Jean-Noël Freund; Hans Clevers; Philippe Jay
Journal:  J Cell Biol       Date:  2004-07-05       Impact factor: 10.539

Review 10.  Wnt signaling in cancer.

Authors:  T Zhan; N Rindtorff; M Boutros
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.